| Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing E Sechi, M Buciuc, SJ Pittock, JJ Chen, JP Fryer, SM Jenkins, A Budhram, ... JAMA neurology 78 (6), 741-746, 2021 | 138 | 2021 |
| Comparison of MRI lesion evolution in different central nervous system demyelinating disorders E Sechi, KN Krecke, SA Messina, M Buciuc, SJ Pittock, JJ Chen, ... Neurology 97 (11), e1097-e1109, 2021 | 88 | 2021 |
| Protein contributions to brain atrophy acceleration in Alzheimer’s disease and primary age-related tauopathy KA Josephs, PR Martin, SD Weigand, N Tosakulwong, M Buciuc, ... Brain 143 (11), 3463-3476, 2020 | 54 | 2020 |
| Long-term outcomes in patients with myelin oligodendrocyte glycoprotein immunoglobulin G–associated disorder AS Lopez-Chiriboga, E Sechi, M Buciuc, JJ Chen, SJ Pittock, ... JAMA neurology 77 (12), 1575-1577, 2020 | 50 | 2020 |
| A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech KA Josephs, JR Duffy, HM Clark, RL Utianski, EA Strand, MM Machulda, ... Nature communications 12 (1), 3452, 2021 | 44 | 2021 |
| Sensitivity–specificity of tau and amyloid β positron emission tomography in frontotemporal lobar degeneration A Ghirelli, N Tosakulwong, SD Weigand, HM Clark, F Ali, H Botha, ... Annals of neurology 88 (5), 1009-1022, 2020 | 37 | 2020 |
| Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy M Buciuc, H Botha, ME Murray, CG Schwarz, ML Senjem, DT Jones, ... Neurology 95 (1), e23-e34, 2020 | 30 | 2020 |
| Lewy body disease is a contributor to logopenic progressive aphasia phenotype M Buciuc, JL Whitwell, K Kasanuki, J Graff‐Radford, MM Machulda, ... Annals of neurology 89 (3), 520-533, 2021 | 26 | 2021 |
| Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder E Sechi, M Buciuc, EP Flanagan, SJ Pittock, SA Banks, ... Multiple Sclerosis and Related Disorders 47, 102638, 2021 | 24 | 2021 |
| Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders V Redenbaugh, M Montalvo, E Sechi, M Buciuc, JP Fryer, A McKeon, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (4 …, 2021 | 23 | 2021 |
| Effect modifiers of TDP-43-associated hippocampal atrophy rates in patients with Alzheimer’s disease neuropathological changes M Buciuc, AM Wennberg, SD Weigand, ME Murray, ML Senjem, ... Journal of Alzheimer's Disease 73 (4), 1511-1523, 2020 | 20 | 2020 |
| MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous KA Josephs, N Tosakulwong, J Graff‐Radford, SD Weigand, M Buciuc, ... Annals of Clinical and Translational Neurology 7 (5), 707-721, 2020 | 19 | 2020 |
| Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer’s disease: a case-control study M Buciuc, JL Whitwell, N Tosakulwong, SD Weigand, ME Murray, ... Neurobiology of aging 92, 92-97, 2020 | 17 | 2020 |
| The many faces of globular glial tauopathy: A clinical and imaging study M Buciuc, S Koga, NTT Pham, JR Duffy, DS Knopman, F Ali, BF Boeve, ... European journal of neurology 30 (2), 321-333, 2023 | 14 | 2023 |
| Frequency of asymptomatic optic nerve enhancement in a large retrospective cohort of patients with aquaporin-4+ NMOSD SS Shah, P Morris, M Buciuc, D Tajfirouz, DM Wingerchuk, ... Neurology 99 (8), e851-e857, 2022 | 13 | 2022 |
| Investigating heterogeneity and neuroanatomic correlates of longitudinal clinical decline in atypical Alzheimer disease JL Whitwell, PR Martin, J Graff-Radford, MM Machulda, I Sintini, M Buciuc, ... Neurology 98 (24), e2436-e2445, 2022 | 13 | 2022 |
| Relationship between 18F-flortaucipir uptake and histologic lesion types in 4-repeat tauopathies KA Josephs, N Tosakulwong, SD Weigand, M Buciuc, VJ Lowe, ... Journal of Nuclear Medicine 63 (6), 931-935, 2022 | 12 | 2022 |
| Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease SB Syc-Mazurek, JJ Chen, P Morris, E Sechi, J Mandrekar, JM Tillema, ... Neurology 99 (18), 795-799, 2022 | 11 | 2022 |
| Old age genetically confirmed frontotemporal lobar degeneration with TDP‐43 has limbic predominant TDP‐43 deposition M Buciuc, JL Whitwell, MC Baker, R Rademakers, DW Dickson, ... Neuropathology and applied neurobiology 47 (7), 1050-1059, 2021 | 11 | 2021 |
| Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: a population-based case-control study E Sechi, S Messina, BM Keegan, M Buciuc, SJ Pittock, OH Kantarci, ... Multiple Sclerosis Journal 27 (5), 667-673, 2021 | 10 | 2021 |
Dennis W. DicksonMayo ClinicVerified email at mayo.edu
